Legend Biotech Files 6-K Reporting Status
Ticker: LEGN · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, compliance, reporting
TL;DR
Legend Biotech filed a routine 6-K, just confirming their reporting status. No new info.
AI Summary
Legend Biotech Corporation filed a Form 6-K on December 9, 2024, reporting its status as a foreign private issuer. The company, incorporated in E9 with its principal executive office in Somerset, New Jersey, is required to file annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its reporting obligations.
Why It Matters
This filing confirms Legend Biotech's compliance with SEC reporting requirements for foreign private issuers, indicating ongoing regulatory adherence.
Risk Assessment
Risk Level: low — This is a standard procedural filing with no new material information that would typically impact stock price or introduce new risks.
Key Players & Entities
- Legend Biotech Corporation (company) — Filer of the Form 6-K
- Somerset, New Jersey (location) — Location of principal executive office
- 001-39307 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer either is required to make public pursuant to the laws of its home country, or is required to publish or distribute to its security holders, or files with a stock exchange on which it has securities listed.
What does it mean that Legend Biotech is a 'foreign private issuer'?
A 'foreign private issuer' is a foreign entity that is not owned by a U.S. issuer and has a majority of its outstanding voting securities held by persons who are not U.S. residents.
Which form does Legend Biotech file for its annual reports?
Legend Biotech files its annual reports under cover of Form 20-F.
Where is Legend Biotech's principal executive office located?
Legend Biotech's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey 08873.
Does this Form 6-K contain specific financial results or operational updates?
No, this Form 6-K primarily serves to report the company's status as a foreign private issuer and its filing obligations, and does not contain specific financial results or operational updates.
Filing Stats: 343 words · 1 min read · ~1 pages · Grade level 14.7 · Accepted 2024-12-09 19:35:04
Filing Documents
- f6k_120924.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 40KB
- 0001171843-24-006838.txt ( ) — 48KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Legend Biotech Corporation (Registrant) Date: December 9, 2024 /s/ Ying Huang Ying Huang, Ph.D. Chief Executive Officer